Pharmacophore modeling and three-dimensional database searching for drug design using catalyst.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Current Medicinal Chemistry

• Publication date

  2001-06-30

• Fields of study

  Biology, Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.2174/0929867013372481PMID 11472240
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Building a common feature hypothesis for thymidylate synthase inhibition.

  2000cited by this paper
• Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening.

  2000cited by this paper
• Developing a dynamic pharmacophore model for HIV-1 integrase.

  2000cited by this paper
• First pharmacophoric hypothesis for 5-HT7 antagonism.

  2000cited by this paper
• Derivation of pharmacophore and CoMFA models for leukotriene D(4) receptor antagonists of the quinolinyl(bridged)aryl series.

  2000cited by this paper
• Ligand design for alpha1 adrenoceptor subtype selective antagonists.

  2000cited by this paper
• Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors.

  1999cited by this paper
• Three-dimensional-quantitative structure activity relationship analysis of cytochrome P-450 3A4 substrates.

  1999cited by this paper
• Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors.

  1999cited by this paper
• Three-dimensional pharmacophore hypotheses for the locust neuronal octopamine receptor (OAR3). Part 2: agonists.

  1999cited by this paper
• Substrate specificity of the ileal and the hepatic Na(+)/bile acid cotransporters of the rabbit. I. Transport studies with membrane vesicles and cell lines expressing the cloned transporters.

  1999cited by this paper
• Pharmacophore development for corticotropin-releasing hormone: new insights into inhibitor activity.

  1999cited by this paper
• Three-dimensional pharmacophore hypotheses of octopamine receptor responsible for the inhibition of sex-pheromone production in Helicoverpa armigera.

  1999cited by this paper
• Three-dimensional quantitative structure activity relationship analyses of substrates for CYP2B6.

  1999cited by this paper
• Definition of a Pharmacophore for Partial Agonists of Serotonin 5-HT3 Receptors

  1999cited by this paper
• Substrate specificity of the ileal and the hepatic Na(+)/bile acid cotransporters of the rabbit. II. A reliable 3D QSAR pharmacophore model for the ileal Na(+)/bile acid cotransporter.

  1999cited by this paper
• Pharmacophores incorporating numerous excluded volumes defined by X-ray crystallographic structure in three-dimensional database searching: application to the thyroid hormone receptor.

  1998cited by this paper
• Identification of novel farnesyl protein transferase inhibitors using three-dimensional database searching methods.

  1997cited by this paper
• Identification of Common Functional Configurations Among Molecules

  1996cited by this paper
• A genetic algorithm for flexible molecular overlay and pharmacophore elucidation

  1995cited by this paper
• CAVEAT: A program to facilitate the design of organic molecules

  1994cited by this paper
• Structure-Based Strategies for Drug Design and Discovery

  1992cited by this paper
• An integrated approach to three-dimensional information management with MACCS-3D

  1991cited by this paper
• ALADDIN: An integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional molecular structures

  1989cited by this paper
• Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.

  1988cited by this paper

• The discovery of natural-product inhibitors targeting white spot syndrome virus dUTPase (WSV112) through virtual screening and bioassays

  2026cites this paper
• Discovery of New HER2 Inhibitors via Computational Docking, Pharmacophore Modeling, and Machine Learning

  2025cites this paper
• From pharmacophore predictions to pharmaceutical possibilities: an integrated approach to screen M3 selective muscarinic receptor antagonist

  2025cites this paper
• Pharmacophore-based design by learning on voxel grids

  2025cites this paper
• A robust computational quest: Discovering potential hits to improve the treatment of pyrazinamide‐resistant Mycobacterium tuberculosis

  2024cites this paper
• Chemical Synthesis, Biological Evaluation, and Cheminformatics Analysis of a Group of Chlorinated Diaryl Sulfonamides: Promising Inhibitors of Cholesteryl Ester Transfer Protein.

  2024cites this paper
• Importance of Computer-Aided Drug Design in Modern Pharmaceutical Research.

  2024cites this paper
• Ligand-based pharmacophore modeling and machine learning for the discovery of potent aurora A kinase inhibitory leads of novel chemotypes

  2024cites this paper
• Hybrid Virtual Screening Approach to Predict Novel Natural Compounds against HIV-1 CCR5.

  2024cites this paper
• Catalytic Enantioselective Cycloaddition Transformation of Tricyclic Arenes Enabled by a Dual-Role Chiral Cage-Reactor

  2024cites this paper
• Biochemical interaction of twenty steroid derivatives with ribosomal protein kinase 4 S6 (RSK-4) surface using a theoretical model

  2024cites this paper
• Discovery of novel cholesteryl ester transfer protein (CETP) inhibitors by a multi-stage virtual screening

  2024cites this paper
• Breakthroughs in AI and multi-omics for cancer drug discovery: A review.

  2024cites this paper
• Unravelling the protective effects of peptide isolated from marine sponge extract MS01 against SH-SY5Y cell line and its in-silico pharmacokinetic analysis

  2024cites this paper
• Fundamentals of Molecular Docking and Comparative Analysis of Protein–Small-Molecule Docking Approaches

  2023cites this paper
• Computational Chemistry for the Identification of Lead Compounds for Radiotracer Development

  2023cites this paper
• Exploration of a Large Virtual Chemical Space: Identification of Potent Inhibitors of Lactate Dehydrogenase-A against Pancreatic Cancer

  2023cites this paper
• Computational Approaches to Designing Antiviral Drugs against COVID-19: A Comprehensive Review.

  2023cites this paper
• Computational workflow for discovering small molecular binders for shallow binding sites by integrating molecular dynamics simulation, pharmacophore modeling, and machine learning: STAT3 as case study

  2023cites this paper
• Development of phosphoinositide 3-kinase delta (PI3Kδ) inhibitors as potential anticancer agents through the generation of ligand-based pharmacophores and biological screening

  2023cites this paper
• LSD1-Based Reversible Inhibitors Virtual Screening and Binding Mechanism Computational Study

  2023cites this paper
• Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of Plasmodium falciparum with Favourable ADME Profiles

  2023influential citation
• Expanding the therapeutic arsenal against cancer: a computational investigation of hybrid xanthone derivatives as selective Topoisomerase 2α ATPase inhibitors

  2023cites this paper
• Discovery of new PKN2 inhibitory chemotypes via QSAR-guided selection of docking-based pharmacophores

  2022cites this paper
• Pharmaceutical interest of in-silico approaches

  2022cites this paper
• Review on molecular docking analysis of herbal compounds and their activity against SARS and JEV using In-silico and In vitro approaches

  2022cites this paper
• Identification of novel xanthine oxidase inhibitors via virtual screening with enhanced characterization of molybdopterin binding groups.

  2022cites this paper
• 3D QSAR Analysis of a Set of Pneumocystis carinii DHFR Inhibitors through Pharmacophore Generation Approach

  2022cites this paper
• IDENTIFICATION OF NEW CYCLOOXYGENASE-2 SELECTIVE INHIBITORS VIA VIRTUAL SCREENING AND COMPLEX-BASED PHARMACOPHORE MAPPING

  2022cites this paper
• VRPharmer: bringing virtual reality into pharmacophore-based virtual screening with interactive exploration and realistic visualization

  2022cites this paper
• Network analysis and ligand-based pharmacophore modeling for discovery of small molecule against glioblastoma multiforme.

  2022cites this paper
• Applications of the Novel Quantitative Pharmacophore Activity Relationship Method QPhAR in Virtual Screening and Lead-Optimisation

  2022cites this paper
• Galileo: Three-dimensional searching in large combinatorial fragment spaces on the example of pharmacophores

  2022cites this paper
• Exploiting activity cliffs for building pharmacophore models and comparison with other pharmacophore generation methods: sphingosine kinase 1 as case study

  2022cites this paper
• Pharmacophore Modeling of Targets Infested with Activity Cliffs via Molecular Dynamics Simulation Coupled with QSAR and Comparison with other Pharmacophore Generation Methods: KDR as Case Study

  2022cites this paper
• Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process

  2022cites this paper
• Current Trends in GPCR Allostery

  2021cites this paper
• Discovery of novel isoform-selective histone deacetylases 5 and 9 inhibitors through combined ligand-based pharmacophore modeling, molecular mocking, and molecular dynamics simulations for cancer treatment.

  2021cites this paper
• A promising in silico protocol to develop novel PPARγ antagonists as potential anticancer agents: Design, synthesis and experimental validation via PPARγ protein activity and competitive binding assay

  2021cites this paper
• Comprehensive strategies of machine-learning-based quantitative structure-activity relationship models

  2021cites this paper
• In Silico Drug Designing for ala438 Deleted Ribosomal Protein S1 (RpsA) on the Basis of the Active Compound Zrl15

  2021cites this paper
• Virtual screening of epalrestat mimicking selective ALR2 inhibitors from natural product database: auto pharmacophore, ADMET prediction and molecular dynamics approach

  2021cites this paper
• Computational Investigation Identified Potential Chemical Scaffolds for Heparanase as Anticancer Therapeutics

  2021influential citation
• Ligand-based pharmacophore modeling: A technique utilized for virtual screening of commercial databases

  2021cites this paper
• Computer-Aided Drug Design

  2021cites this paper
• An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints

  2021cites this paper
• Mathematical Multidimensional Modelling and Structural Artificial Intelligence Pipelines Provide Insights for the Designing of Highly Specific AntiSARS-CoV2 Agents

  2021cites this paper
• Design and development of novel inhibitors of aldo-ketoreductase 1C1 as potential lead molecules in treatment of breast cancer

  2021cites this paper
• ePharmer: An integrated and graphical software for pharmacophore‐based virtual screening

  2021cites this paper
• Molecular docking analysis of α-Topoisomerase II with δ-Carboline derivatives as potential anticancer agents

  2021cites this paper
• Potential inhibitors of methionine aminopeptidase type II identified via structure-based pharmacophore modeling

  2021cites this paper
• Pharmacophore Modeling and Molecular Docking-Based Virtual Screening of Adenosine A2A Inhibitor as Antiparkinson

  2021cites this paper
• Identification of xanthine oxidase inhibitors through hierarchical virtual screening

  2020cites this paper
• Pharmacophore and Molecular Docking-Based Virtual Screening of B-Cell Lymphoma 2 (BCL 2) Inhibitor from Zinc Natural Database as Anti-Small Cell Lung Cancer

  2020cites this paper
• Structure-based virtual screening of dipeptidyl peptidase 4 inhibitors and their in vitro analysis

  2020cites this paper
• Improved Scaffold Hopping in Ligand-Based Virtual Screening Using Neural Representation Learning

  2020cites this paper
• Identification of Novel TRPC5 Inhibitors by Pharmacophore-Based and Structure-Based Approaches

  2020cites this paper
• A systematic strategy for the investigation of vaccines and drugs targeting bacteria

  2020cites this paper
• Identification of potential indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors by an FBG-based 3D QSAR pharmacophore model.

  2020cites this paper
• Identification of natural products as selective PTP1B inhibitors via virtual screening.

  2020cites this paper
• eSHAFTS: Integrated and graphical drug design software based on 3D molecular similarity

  2019cites this paper
• Ligand Based Pharmacophore Modeling Followed by Biological Screening Lead to Discovery of Novel PDK1 Inhibitors as Anticancer Agents.

  2019cites this paper
• Identification of a new small molecule chemotype of Melanin Concentrating Hormone Receptor-1 antagonists using pharmacophore-based virtual screening.

  2019cites this paper
• Repurposing approach identifies new treatment options for invasive fungal disease.

  2019cites this paper
• Molecular Modelling Studies of Novel COX-2 Inhibitors

  2019cites this paper
• Promising Terpenes as Natural Antagonists of Cancer: An In-Silico Approach

  2019cites this paper
• Current Computational Approaches for the Development of Anti-HIV Inhibitors: An Overview.

  2019cites this paper
• Synthesis, Characterization and In vitro Evaluation of N-Substituted- Sulfomoyl-Phenyl-Amino Carboxylic Acid Derivatives as Squalene Synthase Inhibitors

  2019cites this paper
• Discovery of new JNK3 inhibitory chemotypes via QSAR-Guided selection of docking-based pharmacophores and comparison with other structure-based pharmacophore modeling methods.

  2019cites this paper
• Discovery of new Phosphoinositide 3-kinase delta (PI3Kδ) inhibitors via virtual screening using crystallography-derived pharmacophore modelling and QSAR analysis.

  2019cites this paper
• Applications of Molecular Simulation in the Discovery of Anti-tuberculosis Drugs: A Review.

  2019cites this paper
• Identification of essential 2D and 3D chemical features for discovery of the novel tubulin polymerization inhibitors.

  2019cites this paper
• Pharmacophore studies of 1, 3, 4-oxadiazole nucleus: Lead compounds as α-glucosidase inhibitors.

  2019cites this paper
• High-Throughput Virtual Screening (HTVS) of Natural Compounds and Exploration of Their Biomolecular Mechanisms

  2019cites this paper
• Design and synthesis of muscarinic acetylcholine receptor (mAChR) antagonist: pharmacophore-based screening and structure-based optimization

  2019cites this paper
• Virtual Screening and Its Applications in Drug Discovery Process

  2019cites this paper
• Discovery of Novel Glucagon Receptor Antagonists Using Combined Pharmacophore Modeling and Docking

  2018cites this paper
• All in One: Cavity Detection, Druggability Estimate, Cavity-Based Pharmacophore Perception, and Virtual Screening

  2018cites this paper
• In search of the representative pharmacophore hypotheses of the enzymatic proteome of Plasmodium falciparum: a multicomplex-based approach

  2018cites this paper
• Discovery of CNS-Like D3R-Selective Antagonists Using 3D Pharmacophore Guided Virtual Screening

  2018cites this paper
• Pharmacophore-driven identification of N-methyl-D-receptor antagonists as potent neuroprotective agents validated using in vivo studies

  2018cites this paper
• Ligand-based modeling of Akt3 lead to potent dual Akt1/Akt3 inhibitor.

  2018cites this paper
• New Resensitizers for the Nicotinic Acetylcholine Receptor by Ligand-Based Pharmacophore Modeling.

  2018cites this paper
• Exploration of Mycobacterium tuberculosis structural proteome: An in-silico approach.

  2018cites this paper
• Reverse Screening Methods to Search for the Protein Targets of Chemopreventive Compounds

  2018cites this paper
• Drug Discovery: An In Silico Approach

  2018cites this paper
• Reaction-Driven Fragment-Based Design of Viral Protease Inhibitors

  2018cites this paper
• Computational Modeling of Multi-target-Directed Inhibitors Against Alzheimer’s Disease

  2018cites this paper
• Combining Stochastic Deformation/Relaxation and Intermolecular Contacts Analysis for Extracting Pharmacophores from Ligand-Receptor Complexes

  2018cites this paper
• Computational Drug Design and Molecular Dynamic Studies-A Review

  2017cites this paper
• Ligand-based computational modelling of platelet-derived growth factor beta receptor leading to new angiogenesis inhibitory leads

  2017cites this paper
• Discovery of novel potent nuclear factor kappa‐B inhibitors (IKK‐β) via extensive ligand‐based modeling and virtual screening

  2017cites this paper
• Simulated annealing molecular dynamics and ligand-receptor contacts analysis for pharmacophore modeling.

  2017cites this paper
• Novel virtual lead identification in the discovery of hematopoietic cell kinase (HCK) inhibitors: application of 3D QSAR and molecular dynamics simulation

  2017cites this paper
• Acute Neuroinflammation Promotes Cell Responses to 1800 MHz GSM Electromagnetic Fields in the Rat Cerebral Cortex

  2017cites this paper
• Computer Aided Drug Design for Multi-Target Drug Design: SAR /QSAR, Molecular Docking and Pharmacophore Methods.

  2017cites this paper
• The Significance of Discovery Screening and Structure Optimization Studies

  2016cites this paper
• Practical Aspects of Building, Validation and Application of 3D-Pharmacophore Models

  2016cites this paper
• Overview on the current status on virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part II.

  2016cites this paper
• Identification of potential CCR5 inhibitors through pharmacophore-based virtual screening, molecular dynamics simulation and binding free energy analysis.

  2016cites this paper